한국임상수의학회지 (Journal of Veterinary Clinics)

  • 제36권3호
  • /
  • Pages.150-154
  • /
  • 2019
  • /
  • 1598-298X(pISSN)
  • /
  • 2384-0749(eISSN)
한국임상수의학회 (The Korean Society of Veterinary Clinics)
권호 표지
DOI QR코드

DOI QR Code

A Retrospective Study on Canine Epilepsy: Etiological Distribution, Therapeutic Outcome, and Survival Time

  • Park, Seo-Yeon (Veterinary Medical Center, College of Veterinary Medicine, Chungbuk National University) ;
  • Jeong, Yoonsoo (Veterinary Medical Center, College of Veterinary Medicine, Chungbuk National University) ;
  • Yun, Taesik (Veterinary Medical Center, College of Veterinary Medicine, Chungbuk National University) ;
  • Jung, Dong-In (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) ;
  • Chang, Dong-Woo (Veterinary Medical Center, College of Veterinary Medicine, Chungbuk National University) ;
  • Kang, Ji-Houn (Veterinary Medical Center, College of Veterinary Medicine, Chungbuk National University) ;
  • Yang, Mhan-Pyo (Veterinary Medical Center, College of Veterinary Medicine, Chungbuk National University) ;
  • Kang, Byeong-Teck (Veterinary Medical Center, College of Veterinary Medicine, Chungbuk National University)
  • 투고 : 2019.01.30
  • 심사 : 2019.06.02
  • 발행 : 2019.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The purpose of this study was to investigate the etiological distribution, therapeutic outcome, and survival time in canine epilepsy. The medical records of 57 epileptic dogs were reviewed for the evaluation of etiological distribution. Among them, 27 dogs (47%) and 30 dogs (52%) had idiopathic epilepsy (IdE) and structural epilepsy (StE), respectively. Twenty-nine dogs (IdE: 16 dogs, StE: 13 dogs) were evaluated for therapeutic outcome and survival time. The incidence of generalized epileptic seizure (IdE, 56% vs. StE, 44%; P = 0.043) and the median seizure frequency at the time of first presentation (IdE, 2.0/month vs. StE, 13.3/month; P < 0.01) were significantly different between the two groups. Although pre-treatment seizure frequency and duration were not different, the median duration of seizure in the IdE group (0.5 min) was significantly shorter than that in the StE group (3 min) after treatment (P < 0.01). In addition, the median frequency of seizure was relatively lower in the IdE group (0.25/month) compared to the StE group (2.00/month) following antiepileptic therapy (P = 0.053). The median survival time of the IdE group (1.5 years [95% CI, 1.0-2.3 years]) was significantly longer than that of the StE group (0.4 year [95% CI, 0.2-1.3 years]) (P < 0.01). The information on etiological data and intracranial lesions may be useful for predicting treatment response and prognosis in epileptic dogs.

키워드

참고문헌

  1. Armasu M, Packer R, Cook S, Solcan G, Volk H. An exploratory study using a statistical approach as a platform for clinical reasoning in canine epilepsy. Vet J 2014; 202: 292-296. https://doi.org/10.1016/j.tvjl.2014.08.008
  2. Arrol L, Penderis J, Garosi L, Cripps P, Gutierrez-Quintana R, Goncalves R. Aetiology and long-term outcome of juvenile epilepsy in 136 dogs. Vet Rec 2012; 170: 335. https://doi.org/10.1136/vr.100316
  3. Berendt M, Farquhar RG, Mandigers PJ, Pakozdy A, Bhatti SF, De Risio L, Volk HA. International veterinary epilepsy task force consensus report on epilepsy definition, classification and terminology in companion animals. BMC Vet Res 2015; 11: 182. https://doi.org/10.1186/s12917-015-0461-2
  4. Blume WT, Luders HO, Mizrahi E, Tassinari C, van Emde Boas W, Engel J. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 2001; 42: 1212-1218. https://doi.org/10.1046/j.1528-1157.2001.22001.x
  5. Boothe DM, Dewey C, Carpenter DM. Comparison of phenobarbital with bromide as a first-choice antiepileptic drug for treatment of epilepsy in dogs. J Am Vet Med Assoc 2012; 240: 1073-1083. https://doi.org/10.2460/javma.240.9.1073
  6. Cha J, Kim S, Heo S, Lee D, Kim J, Kim J, Kim M. Potential seizurogenic effect of tramadol in a jindo dog with necrotizing meningoencephalitis. J Vet Clin 2011; 28: 323-327.
  7. Chandler K. Canine epilepsy: what can we learn from human seizure disorders? Vet J 2006; 172: 207-217. https://doi.org/10.1016/j.tvjl.2005.07.001
  8. Charalambous M, Brodbelt D, Volk HA. Treatment in canine epilepsy - a systematic review. BMC Vet Res 2014; 10: 257. https://doi.org/10.1186/s12917-014-0257-9
  9. Chung JY, Hwang CY, Chae JS, Ahn JO, Kim TH, Seo KW, Youn HY. Zonisamide monotherapy for idiopathic epilepsy in dogs. N Z Vet J 2012; 60: 357-359. https://doi.org/10.1080/00480169.2012.680855
  10. De Risio L, Bhatti S, Munana K, Penderis J, Stein V, Tipold A, Volk HA. International veterinary epilepsy task force consensus proposal: diagnostic approach to epilepsy in dogs. BMC Vet Res 2015; 11: 148. https://doi.org/10.1186/s12917-015-0462-1
  11. Dewey CW, Guiliano R, Boothe DM, Berg JM, Kortz GD, Joseph RJ, Budsberg SC. Zonisamide therapy for refractory idiopathic epilepsy in dogs. J Am Anim Hosp Assoc 2004; 40: 285-291. https://doi.org/10.5326/0400285
  12. Engel J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001; 42: 796-803. https://doi.org/10.1046/j.1528-1157.2001.10401.x
  13. Fredso N, Sabers A, Toft N, Moller A, Berendt M. A single-blinded phenobarbital-controlled trial of levetiracetam as mono-therapy in dogs with newly diagnosed epilepsy. Vet J 2016; 208: 44-49. https://doi.org/10.1016/j.tvjl.2015.10.018
  14. Fredso N, Koch BC, Toft N, Berendt M. Risk factors for survival in a university hospital population of dogs with epilepsy. J Vet Intern Med 2014; 28: 1782-1788. https://doi.org/10.1111/jvim.12443
  15. Hamamoto Y, Hasegawa D, Mizoguchi S, Yu Y, Wada M, Kuwabara T, Fujita M. Retrospective epidemiological study of canine epilepsy in Japan using the International Veterinary Epilepsy Task Force classification 2015 (2003-2013): etiological distribution, risk factors, survival time, and lifespan. BMC Vet Res 2016; 12: 248. https://doi.org/10.1186/s12917-016-0877-3
  16. In S, Jeong J, Park S, Jeon S, Chang J, Kang B, Chang D. Aetiology of 88 Canine Seizure Patients in Korea. J Vet Clin 2015; 32: 18-19.
  17. Jeon KO, Han SM, Ahn JO, Coh YR, Park SC, Kim HT, Youn HY. Application of Levetiracetam as an Effective Seizure Medication in 4 Seizure Patients. J Vet Clin 2014; 31: 4-5.
  18. Jung DI, Park HM. A case of idiopathic epilepsy with triple combination anticonvulsants therapy in a Shih-tzu dog. J Vet Clin 2004; 11: 96-96.
  19. Lee BH, Pyoun HN, Seo KW, Bhang DH, Hwang CY, Youn HY. Zonisamide therapy for idiopathic epilepsy in 12 dogs. J Vet Clin 2007; 123-123.
  20. Mariani CL. Terminology and classification of seizures and epilepsy in veterinary patients. Top Companion Anim Med 2013; 28: 34-41. https://doi.org/10.1053/j.tcam.2013.06.008
  21. Packer RM, Shihab NK, Torres BB, Volk HA. Clinical risk factors associated with anti-epileptic drug responsiveness in canine epilepsy. PLoS One 2014; 9: e106026. https://doi.org/10.1371/journal.pone.0106026
  22. Saito M, Munana KR, Sharp NJ, Olby NJ. Risk factors for development of status epilepticus in dogs with idiopathic epilepsy and effects of status epilepticus on outcome and survival time: 32 cases (1990-1996). J Am Vet Med Assoc 2001; 219: 618-623. https://doi.org/10.2460/javma.2001.219.618
  23. Schmidt D, Loscher W. New developments in antiepileptic drug resistance: an integrative view. Epilepsy Curr 2009; 9: 47-52. https://doi.org/10.1111/j.1535-7511.2008.01289.x
  24. Weissl J, Hulsmeyer V, Brauer C, Tipold A, Koskinen LL, Kyostila K, Fischer A. Disease progression and treatment response of idiopathic epilepsy in Australian Shepherd dogs. J Vet Intern Med 2012; 26: 116-125. https://doi.org/10.1111/j.1939-1676.2011.00853.x
  25. von Klopmann T, Rambeck B, Tipold A. Prospective study of zonisamide therapy for refractory idiopathic epilepsy in dogs. J Small Anim Pract 2007; 48: 134-138. https://doi.org/10.1111/j.1748-5827.2006.00290.x